 Matthew Zipse
Concepts (188)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Catheter Ablation | 25 | 2026 | 355 | 4.290 |
Why?
| | Cardiomyopathies | 16 | 2025 | 335 | 3.600 |
Why?
| | Sarcoidosis | 13 | 2025 | 163 | 3.300 |
Why?
| | Atrial Fibrillation | 10 | 2026 | 558 | 1.950 |
Why?
| | Tachycardia, Ventricular | 10 | 2025 | 180 | 1.480 |
Why?
| | Heart Ventricles | 7 | 2025 | 756 | 1.370 |
Why?
| | Defibrillators, Implantable | 11 | 2025 | 382 | 1.320 |
Why?
| | Pacemaker, Artificial | 4 | 2023 | 128 | 1.210 |
Why?
| | Myocarditis | 3 | 2023 | 102 | 1.040 |
Why?
| | Heart Valve Prosthesis | 3 | 2025 | 129 | 1.020 |
Why?
| | Arrhythmias, Cardiac | 5 | 2022 | 355 | 0.990 |
Why?
| | Electrophysiologic Techniques, Cardiac | 4 | 2019 | 82 | 0.900 |
Why?
| | Therapeutic Irrigation | 3 | 2020 | 68 | 0.880 |
Why?
| | Death, Sudden, Cardiac | 5 | 2022 | 232 | 0.860 |
Why?
| | Myocardium | 6 | 2022 | 934 | 0.770 |
Why?
| | Electric Countershock | 5 | 2023 | 126 | 0.760 |
Why?
| | Atrial Appendage | 1 | 2023 | 36 | 0.760 |
Why?
| | Electrocardiography | 7 | 2023 | 665 | 0.740 |
Why?
| | Cardiac Pacing, Artificial | 4 | 2023 | 84 | 0.740 |
Why?
| | Tricuspid Valve | 3 | 2025 | 43 | 0.720 |
Why?
| | Ventricular Function, Right | 3 | 2020 | 297 | 0.660 |
Why?
| | Cardiac Resynchronization Therapy | 2 | 2021 | 63 | 0.630 |
Why?
| | Pericardium | 1 | 2020 | 59 | 0.600 |
Why?
| | Atrial Flutter | 3 | 2025 | 47 | 0.590 |
Why?
| | Ventricular Function, Left | 3 | 2025 | 542 | 0.580 |
Why?
| | Cardiac Catheters | 4 | 2020 | 16 | 0.570 |
Why?
| | Heart Atria | 6 | 2025 | 141 | 0.570 |
Why?
| | Prosthesis Failure | 2 | 2020 | 125 | 0.540 |
Why?
| | Action Potentials | 3 | 2025 | 502 | 0.540 |
Why?
| | Ventricular Premature Complexes | 3 | 2025 | 37 | 0.530 |
Why?
| | Septal Occluder Device | 1 | 2018 | 37 | 0.520 |
Why?
| | Heart Rate | 3 | 2025 | 855 | 0.510 |
Why?
| | Mitral Valve | 2 | 2019 | 95 | 0.480 |
Why?
| | Ebstein Anomaly | 1 | 2016 | 7 | 0.470 |
Why?
| | Adipose Tissue | 1 | 2020 | 645 | 0.450 |
Why?
| | Cardiac Catheterization | 2 | 2020 | 558 | 0.440 |
Why?
| | Adiposity | 1 | 2020 | 532 | 0.440 |
Why?
| | Pulmonary Veins | 1 | 2016 | 107 | 0.430 |
Why?
| | Friedreich Ataxia | 1 | 2016 | 78 | 0.420 |
Why?
| | Electroshock | 1 | 2014 | 145 | 0.420 |
Why?
| | Electrophysiological Phenomena | 1 | 2013 | 59 | 0.390 |
Why?
| | Heart Conduction System | 4 | 2024 | 96 | 0.380 |
Why?
| | Heart Septum | 3 | 2016 | 27 | 0.330 |
Why?
| | Tachycardia, Atrioventricular Nodal Reentry | 2 | 2021 | 28 | 0.330 |
Why?
| | Heart Failure | 5 | 2021 | 2326 | 0.330 |
Why?
| | Endovascular Procedures | 1 | 2016 | 390 | 0.320 |
Why?
| | Cattle | 8 | 2020 | 946 | 0.320 |
Why?
| | Humans | 48 | 2026 | 145475 | 0.310 |
Why?
| | Stroke Volume | 6 | 2025 | 654 | 0.300 |
Why?
| | Cardiomyopathy, Hypertrophic | 3 | 2016 | 143 | 0.300 |
Why?
| | Transcatheter Aortic Valve Replacement | 2 | 2023 | 154 | 0.290 |
Why?
| | Aged | 21 | 2026 | 26153 | 0.290 |
Why?
| | Postoperative Complications | 5 | 2025 | 2970 | 0.290 |
Why?
| | Risk Assessment | 7 | 2025 | 3747 | 0.280 |
Why?
| | Aortic Valve Stenosis | 2 | 2023 | 256 | 0.280 |
Why?
| | Electrodes | 2 | 2018 | 111 | 0.260 |
Why?
| | Male | 31 | 2026 | 72843 | 0.250 |
Why?
| | Time Factors | 8 | 2025 | 7123 | 0.250 |
Why?
| | Anti-Arrhythmia Agents | 3 | 2023 | 144 | 0.240 |
Why?
| | Ethanol | 3 | 2016 | 631 | 0.230 |
Why?
| | Arterial Switch Operation | 1 | 2025 | 16 | 0.230 |
Why?
| | Ablation Techniques | 2 | 2016 | 36 | 0.230 |
Why?
| | Transposition of Great Vessels | 1 | 2025 | 41 | 0.220 |
Why?
| | Risk Factors | 11 | 2026 | 10885 | 0.220 |
Why?
| | Equipment Design | 4 | 2020 | 525 | 0.220 |
Why?
| | Middle Aged | 22 | 2025 | 36215 | 0.220 |
Why?
| | Retrospective Studies | 14 | 2026 | 17291 | 0.210 |
Why?
| | In Vitro Techniques | 3 | 2020 | 1048 | 0.200 |
Why?
| | Echocardiography | 4 | 2025 | 647 | 0.200 |
Why?
| | Heart | 4 | 2022 | 626 | 0.190 |
Why?
| | Treatment Outcome | 11 | 2026 | 11772 | 0.190 |
Why?
| | Aortic Valve | 3 | 2023 | 364 | 0.190 |
Why?
| | Heart Transplantation | 3 | 2025 | 680 | 0.180 |
Why?
| | Ventricular Dysfunction, Left | 2 | 2025 | 394 | 0.170 |
Why?
| | Exercise | 2 | 2026 | 2198 | 0.170 |
Why?
| | Tachycardia, Supraventricular | 1 | 2021 | 49 | 0.170 |
Why?
| | Esophagus | 2 | 2023 | 262 | 0.160 |
Why?
| | Coronary Sinus | 1 | 2020 | 9 | 0.160 |
Why?
| | Accessory Atrioventricular Bundle | 2 | 2020 | 13 | 0.160 |
Why?
| | Bradycardia | 1 | 2021 | 61 | 0.160 |
Why?
| | Cardiac Output | 1 | 2020 | 179 | 0.160 |
Why?
| | Papillary Muscles | 1 | 2019 | 13 | 0.150 |
Why?
| | Tricuspid Valve Insufficiency | 1 | 2019 | 24 | 0.150 |
Why?
| | Aortic Valve Insufficiency | 1 | 2019 | 43 | 0.150 |
Why?
| | Female | 24 | 2026 | 78845 | 0.150 |
Why?
| | Operative Time | 1 | 2020 | 181 | 0.150 |
Why?
| | Myocardial Contraction | 1 | 2020 | 293 | 0.150 |
Why?
| | Prosthesis-Related Infections | 1 | 2020 | 98 | 0.140 |
Why?
| | Esophageal Fistula | 1 | 2019 | 21 | 0.140 |
Why?
| | Systole | 1 | 2019 | 181 | 0.140 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2019 | 63 | 0.140 |
Why?
| | Mitral Valve Insufficiency | 1 | 2019 | 68 | 0.140 |
Why?
| | Heart-Assist Devices | 2 | 2025 | 568 | 0.140 |
Why?
| | Atrioventricular Block | 1 | 2019 | 44 | 0.140 |
Why?
| | Device Removal | 1 | 2020 | 142 | 0.140 |
Why?
| | Prosthesis Implantation | 1 | 2019 | 154 | 0.140 |
Why?
| | Heart Diseases | 2 | 2012 | 341 | 0.140 |
Why?
| | Bundle-Branch Block | 2 | 2023 | 37 | 0.130 |
Why?
| | Endocardium | 1 | 2017 | 31 | 0.130 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2020 | 248 | 0.130 |
Why?
| | Recurrence | 3 | 2026 | 1138 | 0.120 |
Why?
| | Environment | 1 | 2018 | 293 | 0.120 |
Why?
| | Intraoperative Complications | 1 | 2018 | 157 | 0.120 |
Why?
| | Swine | 4 | 2023 | 825 | 0.120 |
Why?
| | Tachycardia, Reciprocating | 1 | 2016 | 5 | 0.120 |
Why?
| | Wolff-Parkinson-White Syndrome | 1 | 2016 | 19 | 0.120 |
Why?
| | Catheters | 1 | 2016 | 74 | 0.120 |
Why?
| | Heart Injuries | 1 | 2016 | 42 | 0.120 |
Why?
| | Predictive Value of Tests | 2 | 2019 | 2121 | 0.110 |
Why?
| | Adult | 13 | 2025 | 40777 | 0.110 |
Why?
| | Heart Block | 1 | 2015 | 41 | 0.110 |
Why?
| | Diagnostic Techniques, Cardiovascular | 1 | 2014 | 16 | 0.110 |
Why?
| | Hospitals | 1 | 2019 | 732 | 0.110 |
Why?
| | Medical Records | 1 | 2015 | 192 | 0.100 |
Why?
| | Registries | 4 | 2025 | 2406 | 0.100 |
Why?
| | Incidence | 5 | 2021 | 2923 | 0.100 |
Why?
| | Artifacts | 1 | 2014 | 143 | 0.100 |
Why?
| | Ultrasonography | 1 | 2017 | 785 | 0.100 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2014 | 152 | 0.100 |
Why?
| | Sarcoidosis, Pulmonary | 2 | 2011 | 98 | 0.090 |
Why?
| | Follow-Up Studies | 5 | 2024 | 5423 | 0.090 |
Why?
| | Animals | 9 | 2023 | 38030 | 0.090 |
Why?
| | Prosthesis Design | 1 | 2014 | 354 | 0.090 |
Why?
| | Disease Progression | 1 | 2019 | 2864 | 0.090 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2017 | 1747 | 0.080 |
Why?
| | Prognosis | 1 | 2019 | 4316 | 0.080 |
Why?
| | Cardiac Surgical Procedures | 1 | 2016 | 610 | 0.080 |
Why?
| | Disease Management | 1 | 2013 | 653 | 0.070 |
Why?
| | Tomography, X-Ray Computed | 1 | 2019 | 2769 | 0.070 |
Why?
| | Temperature | 2 | 2023 | 633 | 0.070 |
Why?
| | Patient Discharge | 1 | 2015 | 992 | 0.070 |
Why?
| | United States | 5 | 2025 | 16098 | 0.060 |
Why?
| | Bundle of His | 1 | 2023 | 19 | 0.050 |
Why?
| | Atrioventricular Node | 1 | 2021 | 15 | 0.040 |
Why?
| | Databases, Factual | 2 | 2020 | 1490 | 0.040 |
Why?
| | Tachycardia | 1 | 2021 | 57 | 0.040 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2022 | 161 | 0.040 |
Why?
| | Radiopharmaceuticals | 1 | 2022 | 205 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2025 | 5905 | 0.040 |
Why?
| | Positron-Emission Tomography | 1 | 2022 | 343 | 0.040 |
Why?
| | Young Adult | 3 | 2025 | 14219 | 0.040 |
Why?
| | Mortality | 1 | 2022 | 378 | 0.040 |
Why?
| | Sus scrofa | 1 | 2018 | 65 | 0.040 |
Why?
| | Necrosis | 1 | 2019 | 244 | 0.040 |
Why?
| | Electric Impedance | 1 | 2018 | 108 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2022 | 1547 | 0.030 |
Why?
| | Artificial Intelligence | 1 | 2023 | 381 | 0.030 |
Why?
| | Myocardial Ischemia | 1 | 2019 | 285 | 0.030 |
Why?
| | Exercise Test | 1 | 2020 | 630 | 0.030 |
Why?
| | Biophysical Phenomena | 1 | 2017 | 67 | 0.030 |
Why?
| | Adolescent | 3 | 2025 | 22530 | 0.030 |
Why?
| | Prosthesis Fitting | 1 | 2016 | 14 | 0.030 |
Why?
| | Thermal Conductivity | 1 | 2016 | 4 | 0.030 |
Why?
| | Activities of Daily Living | 1 | 2020 | 444 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2020 | 1508 | 0.030 |
Why?
| | Hot Temperature | 1 | 2019 | 396 | 0.030 |
Why?
| | Colorado | 2 | 2019 | 4554 | 0.030 |
Why?
| | Models, Animal | 1 | 2017 | 393 | 0.030 |
Why?
| | Reoperation | 1 | 2018 | 633 | 0.030 |
Why?
| | Models, Cardiovascular | 1 | 2016 | 196 | 0.030 |
Why?
| | Hospital Mortality | 1 | 2020 | 1038 | 0.030 |
Why?
| | Hospitals, Low-Volume | 1 | 2015 | 26 | 0.030 |
Why?
| | Retreatment | 1 | 2015 | 79 | 0.030 |
Why?
| | Medicare | 1 | 2021 | 903 | 0.030 |
Why?
| | Materials Testing | 1 | 2016 | 345 | 0.030 |
Why?
| | Hospitals, High-Volume | 1 | 2015 | 50 | 0.030 |
Why?
| | Ventricular Outflow Obstruction | 1 | 2015 | 38 | 0.030 |
Why?
| | Survival Rate | 1 | 2019 | 2090 | 0.030 |
Why?
| | Prospective Studies | 2 | 2019 | 8057 | 0.030 |
Why?
| | International Classification of Diseases | 1 | 2015 | 150 | 0.030 |
Why?
| | Solvents | 1 | 2014 | 112 | 0.020 |
Why?
| | Elective Surgical Procedures | 1 | 2015 | 202 | 0.020 |
Why?
| | Injections | 1 | 2014 | 199 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2025 | 8333 | 0.020 |
Why?
| | Death, Sudden | 1 | 2012 | 26 | 0.020 |
Why?
| | Patient Safety | 1 | 2015 | 356 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2019 | 3413 | 0.020 |
Why?
| | Cohort Studies | 2 | 2012 | 6013 | 0.020 |
Why?
| | Inflammation | 1 | 2022 | 2878 | 0.020 |
Why?
| | Hospitalization | 1 | 2021 | 2460 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2011 | 527 | 0.020 |
Why?
| | Early Diagnosis | 1 | 2011 | 251 | 0.020 |
Why?
| | Models, Biological | 1 | 2016 | 1764 | 0.020 |
Why?
| | Odds Ratio | 1 | 2011 | 1082 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2011 | 1300 | 0.020 |
Why?
| | Biopsy | 1 | 2011 | 1082 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2011 | 1997 | 0.010 |
Why?
| | Logistic Models | 1 | 2011 | 2134 | 0.010 |
Why?
|
|
Zipse's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|